Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation

Open access

Abstract

Inhibitors of BCL-X L , combined with inhibition of the mTOR/4E-BP axis, drive regressions of PIK3CA mutant breast tumors.

Overview

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aae0348

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 57 references

Cited by

See all 53

Metadata

Authors
Anderson, G. R., Wardell, S. E., Cakir, M., Crawford, L., Leeds, J. C., Nussbaum, D. P., Shankar, P. S., Soderquist, R. S., Stein, E. M., Tingley, J. P., Winter, P. S., Zieser-Misenheimer, E. K., Alley, H. M., Yllanes, A., Haney, V., Blackwell, K. L., McCall, S. J., McDonnell, D. P., & Wood, K. C.
Affiliations
  • Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA.
  • Duke University (US)
Corresponding author
Wood, Kris C.
Venue
Science Translational Medicine
Published
2016-12-14
Volume
8
Issue
369
Pages
369ra175-369ra175
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2563571637
Cited by
53
References
57
Citations by year
2025: 4 · 2024: 5 · 2023: 4 · 2022: 10 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 10 · 2017: 2
FWCI
3.29
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
Funders
  • Duke University School of Medicine
  • Duke Cancer Institute
  • NIH Building Interdisciplinary Research Careers in Women’s Health Program (K12HD043446)
  • Golfers Against Cancer Research Award
  • Stewart Trust Fellowship
  • NSF (DGE-1106401, DGF-1106401)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Oncology › Advanced Breast Cancer Therapies
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
PIK3CA mutation, breast cancer, mTOR signaling, 4E-BP, Bcl-xL inhibitors, tumor dependency, combination therapy, PI3K/Akt signaling
MeSH terms
Animals, Breast Neoplasms, DNA Mutational Analysis, Female, Humans, Mice, Nude, Mutation, Neoplasm Transplantation, Gene Expression Regulation, Neoplastic, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Combinatorial Chemistry Techniques, MAP Kinase Signaling System, Cell Line, Tumor, bcl-X Protein, Mice, Class I Phosphatidylinositol 3-Kinases, TOR Serine-Threonine Kinases, Molecular Targeted Therapy, Myeloid Cell Leukemia Sequence 1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. https://app.cochat.ai/papers/10.1126/scitranslmed.aae0348
The paper
Anderson, G. R., Wardell, S. E., Cakir, M., Crawford, L., Leeds, J. C., Nussbaum, D. P., Shankar, P. S., Soderquist, R. S., Stein, E. M., Tingley, J. P., Winter, P. S., Zieser-Misenheimer, E. K., Alley, H. M., Yllanes, A., Haney, V., Blackwell, K. L., McCall, S. J., McDonnell, D. P., & Wood, K. C. (2016). PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aae0348

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.